The impact of age on acceptable measured GFR for living kidney donation by Gaillard, F et al.
outcomes were graft function at 1, 3,5 and 7 years.We also analyzed donor’s and recipi-
ent’s variables impacting the short and long term loss of graft.
RESULTS: Patient survival was comparable among age groups (10-year patient sur-
vival: group 1, 100.0%; group 2, 100.0%; group 3, 92.9%; group 4, 89.3%; group 5,
90.3%; group 6, 90.5%; p¼0.18), whereas graft survival (death censored) was signifi-
cantly reduced in transplants from very elderly donors (10-year graft survival: group 1,
93.9%; group 2, 85.4%; group 3, 96.4%; group 4, 78.6%; group 5, 81.9%; group 6,
71.4%; p¼0.03). As expected, by comparing SKT and DKT, long term graft survival
was better in SKT from donors under 60 years old versus SKT from older donors
(92.0% vs 75.0%, p¼0.001); conversely no difference was found if kidneys from older
donors were allocated for DKT. Likewise, we found no significant difference for patient
or graft survival between SKT and DKT, both from donors> 60 years old (10-year
patient survival: 90.3% vs 89.6%, respectively, p¼0.92; 10-year graft survival: 75.0% vs
83.6%, respectively, p¼0.16). Also, graft function among the six groups was compara-
ble at any considered time point. Finally, univariate analysis showed that re-transplan-
tation is the most important risk factor for graft loss at one year after transplantation
(OR¼6.38, p¼0.003), together with donor’s (OR¼1.13, p¼0.02) and recipient’s age
(OR¼1.11, p¼0.002). None of the other variables seems to affect short and long term
graft survival.
CONCLUSIONS: In our population, donor age classes displayed similar and successful
patients and graft survival rates, and renal function was comparable among groups at
different times. The overlapping outcomes between SKT and DKT in the older donor
group suggest that our allocation system is efficient to avoid underperforming SKT or
DKT excess. The use of pre-implantation biopsy should be revisited as their findings
may be too restrictive to allocate ECD kidneys.
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INTRODUCTIONANDAIMS:Recommendations on the GFR threshold to accept liv-
ing kidney donation are not consensual. The recent K/DIGO guidelines suggested to
reset the conventional cutoff value of 80 to 90mL/min/1.73m2.While GFR physiologi-
cally declines with age, it is unclear whether and how age should be taken into account
for selecting acceptable pre-donation GFR.
METHODS: In this multicentric retrospective study conducted in 2007 kidney donors
in France, we evaluated the impact of age using two thresholds (80 and 90mL/min/
1.73m2). Three groups of donors were defined according to baseline GFR:<80, 80-
89.9,90mL/min/1.73m2.
RESULTS: Thirty-two percent of donors were selected despite a GFR below 90mL/
min/1.73m2. Donors with the lowest GFR were significantly older (6069 years vs. 47
611 years, p<0.0001). The lifetime-standardized renal reserve, defined as the pre-don-
ation mGFR value divided by the expected number of remaining years of life, was simi-
lar across all baseline GFR groups. In a subgroup of 132 donors with repeatedmGFR 5
years after donation, the magnitude of GFR decrease was similar in all groups (-34.3%,
-33.9%, and-34.9% respectively).
CONCLUSIONS: In conclusion, decision to accept individuals with GFR lower than
90mL/min/1.73m2 for kidney donation is highly dependent on the age of the candidate.
Our data suggest that a threshold value lower than 90mL/min/1.73m2 is reasonable for
older donors andmore generally, that considering age-calibrated GFRmay improve
efficiency of the selection process.
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INTRODUCTIONANDAIMS: The objective of this study was to describe the man-
agement of patients undergoing renal transplantation in 2013 and over the following
two years on the basis of healthcare consumption data.
METHODS: The National Health Insurance Information System was used to identify
1,876 general scheme beneficiaries undergoing a first isolated renal transplantation.
RESULTS: Among included people (median age: 53 years;, men 63%). 1.2% of patients
died during the transplantation hospital stay (>65 years 3.3%) and 87% of patients had
a functional graft at 2 years. Thirty-three per cent of patients were readmitted to hospi-
tal for 1 day or longer during the first month, 73% the first year and 55% the second
year. At least 10% of patients were hospitalised for anti-rejection treatment during the
first quarter after renal transplantation, 16% the first year and 9% the second year. The
first year, 32% of patients were hospitalised for renal disease (12% the second year),
14%were hospitalised for cardiovascular disease (9% the second year), 13% for infec-
tious disease (5% the second year), and 2% for a malignant tumour (2% the second
year). Almost 80% of patients consulted their general practitioner each year (almost
50% consulted every quarter). During the second year, 83% of patients were taking
antihypertensives, 45% lipid-lowering drugs, 26% antidiabetic drugs, 77% tacrolimus,
18% ciclosporin, 88%mycophenolic acid and 69% corticosteroids.
CONCLUSIONS: This study highlights the important contribution of healthcare con-
sumption data to a better understanding of the modalities of management of renal
transplant recipients in France, allowing improvement of this management in line with
guidelines.
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INTRODUCTIONANDAIMS:Many end-stage kidney disease patients referred for
kidney transplantation are under the care of nephrology teams external to transplant
centres. However, the following issues are unclear; 1) whether characteristics differ
between internal or external transplant referrals, and 2) whether post-transplant out-
comes differ dependent upon whether patients are internally or externally referred.
METHODS:Data was extracted from hospital informatics systems for all kidney allog-
raft recipients transplanted at our centre between 2007 and 2017. Electronic patient
records were thenmanually searched to facilitate data linkage between various sources
to create a comprehensive database of baseline demographics, donor details, clinical/
biochemical parameters, histology, clinical events and survival outcomes. Mortality,
graft loss, delayed graft function, 1-year rejection and 1-year creatinine values were
crosschecked with registry data obtained from the UK Transplant Registry.
RESULTS:Data was extracted for 1,421 kidney allograft recipients at a single-centre,
with median follow up 746 days (IQR 133-1,750 days) and cumulative 4,088 patient-
years of follow. Baseline demographics were similar apart from internal versus external
patients were more likely to be non-white (36.3% versus 26.5% respectively, p<0.001),
diabetic (9.1% versus 7.6% respectively, p¼0.005), have higher matchability scores (4.7
versus 4.4 respectively, p¼0.095), higher level of HLAmismatch (14.3% versus 11.4%
respectively, p¼0.039) and more likely to be repeat transplant recipients (9.1% versus
5.2% respectively, p<0.001). Post-transplantation, internal versus external patients
had significantly higher risk for both delayed graft function (15.1% versus 10.6%
respectively, p¼0.016) and rejection within the first year (9.5% versus 6.2% respec-
tively, p¼0.026). No difference was detected in length of stay by days (12.5 versus 12.2)
or 1-year creatinine (mmol/L) in surviving kidneys (135 versus 138). While internal
versus external patients had an increased risk for death-censored graft loss (16.6% ver-
sus 8.0% respectively, p<0.001), they had a decreased risk for death (7.5% versus
11.0% respectively, p¼0.019). In a Cox regressionmodel, adjusted for baseline charac-
teristics, internal referrals had an increased risk for death-censored graft loss (HR
1.753, 95% CI 1.150-2.670, p¼0.009) but decreased risk for all-cause mortality (HR
0.396, 95% CI 0.250-0.627, p<0.001). However, with the addition of delayed graft
function and rejection into the Coxmodel, internal referrals no longer had significantly
increased risk for death-censored graft loss (HR 1.551, 95%CI 0.906-2.656, p¼0.109)
but retained a significantly decreased risk for death (HR 0.390, 95%CI 0.219-0.696,
p¼0.001).
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